Surgical Ablative Therapies in Patients With Radiorecurrent Prostate Cancer.
Alice YuMustafa DinckalJulio M Pow-SangPublished in: Cancer control : journal of the Moffitt Cancer Center (2024)
Management of recurrent prostate cancer following radiotherapy and subsequent radical prostatectomy poses considerable challenges due to potential complications for patients. Focal therapies have emerged as a burgeoning approach in prostate cancer treatment. Research indicates that ablative therapies exhibit encouraging oncological efficacy while maintaining acceptable functional outcomes in salvage interventions. Here, we present a contemporary review of focal therapy treatment modalities as well as oncologic and functional outcomes.
Keyphrases
- radical prostatectomy
- prostate cancer
- end stage renal disease
- ejection fraction
- chronic kidney disease
- early stage
- physical activity
- peritoneal dialysis
- risk factors
- locally advanced
- stem cells
- radiation induced
- rectal cancer
- mesenchymal stem cells
- squamous cell carcinoma
- combination therapy
- minimally invasive
- smoking cessation